These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 25047684)
1. HBV preS2 transactivates FOXP3 expression in malignant hepatocytes. Zhang X; Gao L; Liang X; Guo M; Wang R; Pan Y; Liu P; Zhang F; Guo C; Zhu F; Qu C; Ma C Liver Int; 2015 Mar; 35(3):1087-94. PubMed ID: 25047684 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT. Luan F; Liu H; Gao L; Liu J; Sun Z; Ju Y; Hou N; Guo C; Liang X; Zhang L; Sun W; Ma C Gut; 2009 Nov; 58(11):1528-37. PubMed ID: 19651630 [TBL] [Abstract][Full Text] [Related]
3. HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma. Liu P; Zhang H; Liang X; Ma H; Luan F; Wang B; Bai F; Gao L; Ma C Oncotarget; 2015 Oct; 6(30):29048-59. PubMed ID: 26315112 [TBL] [Abstract][Full Text] [Related]
4. Correlation between HBV protein preS2 and tumor markers of hepatocellular carcinoma. Luan F; Liu B; Zhang J; Cheng S; Zhang B; Wang Y Pathol Res Pract; 2017 Sep; 213(9):1037-1042. PubMed ID: 28869105 [TBL] [Abstract][Full Text] [Related]
5. In vitro transfection of the hepatitis B virus PreS2 gene into the human hepatocarcinoma cell line HepG2 induces upregulation of human telomerase reverse transcriptase. Liu H; Luan F; Ju Y; Shen H; Gao L; Wang X; Liu S; Zhang L; Sun W; Ma C Biochem Biophys Res Commun; 2007 Apr; 355(2):379-84. PubMed ID: 17307151 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma. Tang S; Hu W; Hu J; Wu S; Li J; Luo Y; Cao M; Zhou H; Jiang X Liver Int; 2015 Feb; 35(2):608-19. PubMed ID: 24423280 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus PreS2-mutant large surface antigen activates store-operated calcium entry and promotes chromosome instability. Yen TT; Yang A; Chiu WT; Li TN; Wang LH; Wu YH; Wang HC; Chen L; Wang WC; Huang W; Chang CW; Chang MD; Shen MR; Su IJ; Wang LH Oncotarget; 2016 Apr; 7(17):23346-60. PubMed ID: 26992221 [TBL] [Abstract][Full Text] [Related]
8. The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways. Hildt E; Hofschneider PH Recent Results Cancer Res; 1998; 154():315-29. PubMed ID: 10027012 [TBL] [Abstract][Full Text] [Related]
9. Blockade of preS2 down-regulates the apoptosis of HepG2.2.15 cells induced by TRAIL. Liang X; Qu Z; Zhang Z; Du J; Liu Y; Cui M; Liu H; Gao L; Han L; Liu S; Cao L; Zhao P; Sun W Biochem Biophys Res Commun; 2008 May; 369(2):456-63. PubMed ID: 18284918 [TBL] [Abstract][Full Text] [Related]
10. Creation of a six-fingered artificial transcription factor that represses the hepatitis B virus HBx gene integrated into a human hepatocellular carcinoma cell line. Zhao X; Zhao Z; Guo J; Huang P; Zhu X; Zhou X; Yang Z; Zhao L; Xu L; Xu J; Fu L; Zhang J; Zhang X; Dong Y; Huang G; Wang Q; Li B; Song X; Yang X; Liu S; Yi S; Yu T; Yu C; Hou L; Li J; Chen W J Biomol Screen; 2013 Apr; 18(4):378-87. PubMed ID: 23042077 [TBL] [Abstract][Full Text] [Related]
11. [Effects of PreS2 synthetic peptides on infiltrating T lymphocyte subgroups expression in hepatocellular carcinoma]. Zheng SC; Wei XY; Xu CB; Xie HQ Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):415-7. PubMed ID: 12890345 [TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses. Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932 [TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients. Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation. Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422 [TBL] [Abstract][Full Text] [Related]
15. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases. Raimondo G; Costantino L; Caccamo G; Pollicino T; Squadrito G; Cacciola I; Brancatelli S J Hepatol; 2004 Mar; 40(3):515-9. PubMed ID: 15123368 [TBL] [Abstract][Full Text] [Related]
16. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Kekulé AS; Lauer U; Meyer M; Caselmann WH; Hofschneider PH; Koshy R Nature; 1990 Feb; 343(6257):457-61. PubMed ID: 2153938 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis. Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496 [TBL] [Abstract][Full Text] [Related]
19. HBx triggers either cellular senescence or cell proliferation depending on cellular phenotype. Idrissi ME; Hachem H; Koering C; Merle P; Thénoz M; Mortreux F; Wattel E J Viral Hepat; 2016 Feb; 23(2):130-8. PubMed ID: 26316075 [TBL] [Abstract][Full Text] [Related]